What’s next in Indonesia’s healthcare landscape: Digital transformation, preventive care, and early detection

The Indonesian healthcare landscape has improved significantly in the past decade. It has strengthened access to funding through the successful rollout of the BPJS Kesehatan, or universal healthcare, and the successful reforms implemented through the Omnibus Law that we will see in the coming years.

PathGen raises funding from East Ventures and Royal Group Indonesia, making early disease detection and precision medicine more accessible

PathGen or PathGen Diagnostik Teknologi, an Indonesia-based healthcare biotechnology startup specializing in molecular testing solutions, has raised funding from East Ventures and Royal Group Indonesia

Mesh Bio raises US$3.5 million of Series A funding led by East Ventures, to make its digital twin technologies available at scale

Mesh Bio, a Singapore-based health deep tech startup transforming chronic disease management through predictive analytics, announced today that it has raised US$3.5 million in Series A financing led by East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia. This round of investment is also participated by Elev8, Seed Capitals, and other existing shareholders.

East Ventures announced its first Healthcare fund of US$30 million

East Ventures, a pioneering and leading venture capital firm in Indonesia and Southeast Asia, today announced the firm’s first healthcare-focused fund with the amount of US$30 million, which is dedicated to supporting innovative healthcare solutions in Indonesia.

Mesh Bio, a health deep tech startup, secured investment from East Ventures

Mesh Bio, a Singapore-based health deep tech startup in transforming chronic disease management through predictive analytics, announced that it had raised an undisclosed amount of funding from East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia. The funding will be allocated to further develop the digital twin technologies in chronic disease management and to expand its services across Southeast Asia, mainly Indonesia, Malaysia, and the Philippines.

AMILI, a precision gut microbiome firm, raises new funding led by East Ventures

AMILI, Southeast Asia’s first and only precision gut microbiome company, today announced that it has secured new funding from East Ventures, a pioneering sector-agnostic venture capital firm that has supported over 300 tech companies across Southeast Asia. This fund strengthens AMILI’s balance sheet, following the company’s series A funding in June 2022.

One medical health record helps with decision-making: Sharlini Eriza Putri, Co-founder & CEO of Nusantics

Startups are indeed the backbone of the digital economy. Startups play an important role in shaping and developing digital economic ecosystems. While conventional businesses only adapt digitalization for internal systems, transaction needs, and other things. The important thing about the digital economy is that it can provide value to people who previously did not have access.

Vietnam-based telehealth platform Medigo bags US$ 2 million in series A funding led by East Ventures

Medigo, a Vietnam-based telehealth platform that provides on-demand medicine prescription and delivery services, has successfully raised US$ 2 million in a series A funding round led by East Ventures, with the participation from Pavilion Capital and Touchstone Partners. With the added capital, Medigo plans to strengthen its services and develop a healthcare ecosystem in Vietnam.